| Code | CSB-MP884484HU |
| Abbreviation | Recombinant Human VSIR protein, partial (Active) |
| MSDS | |
| Size | $110 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
VSIR functions as an inhibitory checkpoint receptor that dampens T-cell responses in the tumor microenvironment, making it a target of interest in immuno-oncology research. This mammalian-expressed construct spanning residues 33–194 captures the extracellular V-type immunoglobulin domain responsible for ligand engagement, and its native post-translational modifications support conformationally dependent antibody recognition, as demonstrated by an EC50 of 20.84–22.73 ng/mL in functional ELISA with an anti-VSIR recombinant antibody. The validated binding activity provides a suitable basis for therapeutic antibody epitope mapping, competitive inhibition screening, and affinity characterization by surface plasmon resonance or biolayer interferometry in checkpoint-focused drug discovery programs. With purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg, this protein aligns with standards expected in ligand-receptor interaction assays and blocking antibody validation workflows.
There are currently no reviews for this product.